Koselugo (selumetinib) for the Treatment of Neurofibromatosis Type 1 (NF1)
Neurofibromatosis 1 occurs due to mutations in the NF1 gene found on chromosome 17. Credit: Shutterstock + David A Litman
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more